The significance of positron emission tomography in oncology;Bedeutung der positronenemissionstomographie in der onkologie

Onkologe

Volumn 9, Issue 3, 2003, Pages 283-291

  Reinhardt, M J ^a   Von Mallek, D ^a   Rodel R ^a   Biersack, H J ^a  

^a UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADSORPTION; BREAST CARCINOMA; CANCER DIAGNOSIS; COLORECTAL CARCINOMA; COMPUTER ASSISTED TOMOGRAPHY; CORRELATION ANALYSIS; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; DISEASE SEVERITY; ESOPHAGUS CARCINOMA; EXPERIMENT; GASTROINTESTINAL TUMOR; GLUCOSE METABOLISM; HUMAN; INTERMETHOD COMPARISON; LUNG TUMOR; LYMPHOMA; MELANOMA; METASTASIS; MORPHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; ONCOLOGY; OVARY CARCINOMA; PANCREAS CARCINOMA; POSITRON EMISSION TOMOGRAPHY; PROGNOSIS; REVIEW; SENSITIVITY ANALYSIS; SENSITIVITY AND SPECIFICITY; TUMOR LOCALIZATION; UTERINE CERVIX CARCINOMA;

EID: 0038235553     PISSN: 09478965     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00761-003-0486-1     Document Type: Review

References (27)

1. Warburg O (1956) On the origin of cancer cells. Science 123:309-314
2. Hatanaka M (1974) Transport of sugars in tumor cell membranes. Biochim Biophys Acta 355:77-104
3. Monakhov NK, Neistadt EL, Shavlovskil MM, Shvartsman AL, Cifakh SA (1978) Physicochemical properties and isoenzyme composition of hexokinase from normal and malignant human tissues. J Nat Cancer Inst 61:27-34
4. Birnbaum MJ, Haspel HC, Rosen OM (1987) Transformation of rat fibroblasts by FSV rapidly increases glucose. Science 235:1495-1498
5. Flier JS, Mueckler MM, Usher P, Lodish HF (1987) Elevated levels of glucose transport and transporter messenger RNA are induced by ras or src oncogenes. Science 235:1492-1495
6. Reske SN, Grillenberger KG, Glatting G, Port M, Hildebrandt M, Gansauge F, Beger HG (1997) Overexpression of glucose transporter 1 and increased FDG uptake in pancreatic carcinoma. J Nucl Med 38:1344-1348
7. Suzuki K, Iwata R, Tamate K, Yoshikawa K, Ido T (1977) Remote system for the mass production of short-lived radioisotopes in a cyclotron. Development of the system and radioisotope production. Radioisotopes 26:67-73
8. 18F]2-deoxy-2-fluoro-D-glucose. J Nucl Med 19:1154-1161
9. Boerner AR, Weckesser M, Herzog H, Schmitz T, Audretsch W, Nitz U, Bender HG, Mueller-Gaertner HW (1999) Optimal scan time for fluorine-18-fluorodeoxyglucose positron emission tomography in breast cancer. Eur J Nucl Med 26:226-230
10. Kubota K, Itoh M, Ozaki K, Ono S, Tashiro M, Yamaguchi K, Akaizawa T, Yamada K, Fukuda H (2001) Advantage of delayed imaging of whole-body FDG-PET for tumor detection. Eur J Nucl Med 28:696-703
11. Strauss LG, Conti PS (1991) The applications of PET in clinical oncology. J Nucl Med 32:623-648
12. rd German Interdisciplinary Consensus Conference "Onko-PET III", 21 July and 19 September 2000. Eur J Nucl Med 28:1707-1723
13. Qualitätssicherung in der Onkologie (2002) Kurzgefasste Interdisziplinäre Leitlinien 2002. Deutsche Krebsgesellschaft e.V. (Hrsg) Informationszentrum für Standards in der Onkologie (ISTO). Zuckschwerdt, München
14. Gambhir SS, Czernin J, Schwimmer J, Silverman DHS, Coleman RE, Phelps ME (2001) A tabulated summary of the FDG PET literature. J Nucl Med 42: Suppl. 1-93
15. Onkologie systematisch. Diagnostik und interdisziplinäre Therapie maligner Tumoren (1999) Schmitt G (Hrsg) UNI-MED, Bremen
16. Trede M, Schwall G, Saeger HD (1990) Survival after pancreatoduodenectomy. Ann Surg 211:447-458
17. Reinhardt MJ, Ehritt-Braun C, Vogelgesang D, Ihling C, Högerle S, Mix M, Moser E, Krause TM (2001) Metastatic lymph nodes in patients with cervical cancer: detection with MR imaging and FDG PET. Radiology 218:776-782
18. Rose PG, Adler LP, Rodriguez M, Faulhaber PF, Abdul-Karim FW, Miraldi F (1999) PET for evaluating para-aortic nodal metastasis in locally advanced cervical cancer before surgical staging: a surgico-pathologic study. J Clin Oncol 17:41-45
19. Gademann G, Biersack HJ (2001) Radiotherapie und -diagnostik maligner Melanome unter besonderer Berücksichtigung der Positronen-emissionstomographie. Onkologe 7:71-75
20. 18F]-D-glucose. Cancer 82:2227-2234
21. Cremerius U, Fabry U, Neuerburg J, Zimny M, Bares R, Osieka R, Büll U (2001) Prognostic significance of positron emission tomography using fluorine-18-fluorodeoxyglucose in patients treated for malignant melanoma (2001) Nuklearmedizin 40:23-30
22. Grigsby PW, Siegel BA, Dehdashti F (2001) Lymph node staging by positron emission tomography in patients with carcinoma of the cervix. J Clin Oncol 19:3745-3749
23. 18F-FDG uptake as a biologic prognostic factor for recurrence in patients with surgically resected non-small cell lung cancer. J Nucl Med 43:39-45
24. Ell PJ, von Schulthess GK (2002) PET/CT: a new road map. Eur J Nucl Med 29:719-720
25. Beyer T, Townsend DW, Brun T, Kinahan PE, Charron M, Roddy R, Jerin J, Young J, Byars L, Nutt R (2000) A combined PET/CT scanner for clinical oncology. J Nucl Med 41:1369-1379
26. Magnani P, Carretta A, Rizzo G, Fazio F, Vanzulli A, Lucignani G, Zannini P, Messa C, Landoni C, Gilardi MC, del Maschio A (1999) FDG/PET and spiral CT image fusion for mediastinal lymph node assessment of non-small cell lung cancer patients. J Cardiovasc Surg 40:741-748
27. Freudenberg LS, Antoch G, Beyer T, Bockisch A, Debatin J (2002) Erste klinische Erfahrungen mit einem kombinierten PET/CT-Tomographen an der Universität Essen. Electromedica 70:68-73